Skip to main content
Log in

Unchanging Trend of Adenocarcinoma of the Esophagus and Gastric Cardia in Taiwan: A 15-Year Experience in a Single Center

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Chronic gastroesophageal reflux disease is closely associated with esophageal adenocarcinoma and gastric cardia carcinoma, and esophageal adenocarcinoma and gastric cardia carcinoma have both been increasing in Western countries recently. Gastroesophageal reflux disease is not rare in Taiwan, but the frequency of occurrence of esophageal adenocarcinoma or gastric cardia carcinoma has not been studied here to date. Patients diagnosed with esophageal and gastric cancers at this hospital between 1981 and 1995 were recruited using the hospital tumor registry database. There were 45, 1546, 970, and 4167 patients diagnosed with esophageal adenocarcinoma, esophageal squamous cell carcinoma, gastric cardia carcinoma, and gastric noncardia adenocarcinoma, respectively. The ratios of esophageal adenocarcinoma versus esophageal squamous cell carcinoma among the three cohorts were 0.030, 0.016, and 0.041, respectively (trend, P = 0.086). The corresponding values for gastric cardia carcinoma versus gastric noncardia adenocarcinoma were 0.252, 0.232, and 0.218, respectively (trend, P = 0.256). The ratios of esophageal adenocarcinoma versus esophageal squamous cell carcinoma and of gastric cardia carcinoma versus gastric noncardia adenocarcinoma have not risen in the three cohorts. Unlike the situation in Western countries, the incidence of esophageal adenocarcinoma and gastric cardia carcinoma versus esophageal squamous cell carcinoma and gastric noncardia adenocarcinoma have not increased over the past 15 years among the Chinese in Taiwan. Although gastroesophageal reflux disease is common here, its definite pathogenesis leading to esophageal adenocarcinoma or gastric cardia carcinoma remains unresolved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049–2053, 1998

    Article  PubMed  Google Scholar 

  2. Freeny PC: Adenocarcinoma of the esophagus and gastroesophageal junction. Semin Roentgenol 29:373–386, 1994

    PubMed  Google Scholar 

  3. Sharma VK, Chockalingam H, Hornung CA, Vasudeva R, Howden CW: Changing trends in esophageal cancer: A 15-year experience in single center. Am J Gastroenterol 93:702–705, 1998

    PubMed  Google Scholar 

  4. Chen PC, Wu CS, Chang-Chien CS, Liaw YF: Comparison of Olympus GIF-P2 and GIF-K panendoscopy. Taiwan I Hsueh Hui Tsa Chih J Formosan Med Assoc 78:136–140, 1979

    Google Scholar 

  5. Department of Health: Directory of Nutrition for People of the Republic of China. Executive Yuan, Republic of China, 1991

  6. Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R: Erosive esophagitis and Barrett's esophagus in Taiwan: A higher frequency than expected. Dig Dis Sci 42:702–706, 1997

    PubMed  Google Scholar 

  7. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831, 1999

    Article  PubMed  Google Scholar 

  8. Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett's esophagus: Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 118:543–549, 1983

    PubMed  Google Scholar 

  9. Altorki NK, Oliveria S, Schrump DS: Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 13:270–280, 1997

    PubMed  Google Scholar 

  10. Drewitz DJ, Sampliner RE, Garewal HS: The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92:212–215, 1997

    PubMed  Google Scholar 

  11. Stoker DL, Williams JG, Leicester RG, Colin-Jones DG: Oesophagitis: A five year review. Gut 29:A1450, 1988

    Google Scholar 

  12. Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M: Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 86:965–970, 1991

    PubMed  Google Scholar 

  13. Vaughan TL, Davis S, Kristal A, Thomas DB: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomark Prev 4:85–92, 1995

    Google Scholar 

  14. Gray JR, Coldman AJ, MacDonald WC: Cigarrette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 69:2227–2231, 1992

    PubMed  Google Scholar 

  15. Brown LM, Swanson CA, Gridley G, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG: Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer 87:104–109, 1995

    Google Scholar 

  16. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: A meta-analysis among different ethnic groups. Int J Obes 22:1164–1171, 1998

    Google Scholar 

  17. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley PK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131, 1991

    PubMed  Google Scholar 

  18. Hansson LE, Engstrand L, Nyren O, Evans DJ Jr, Lindgren A, Bergstrom R, Andersson B, Athlin L, Bendtsen O, Tracz P: Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterolgy 105:1098–1103, 1993

    Google Scholar 

  19. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains processing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115, 1995

    PubMed  Google Scholar 

  20. Parsonnet J, Friedman GD, Orentreich N, Vogelman JH: Risk for gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut 40:297–301, 1997

    PubMed  Google Scholar 

  21. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr: An inverse relation between cagA strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588–590, 1998

    PubMed  Google Scholar 

  22. Teh BH, Lin JT, Pan WH, Lin SH, Wang LY, Lee TK, Chen CJ: Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res 14:1389–1392, 1994

    PubMed  Google Scholar 

  23. Yang JC, Wang TH, Wang HJ, Kuo CH, Wang JT, Wang WC: Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 92:1316–1321, 1997

    PubMed  Google Scholar 

  24. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ: Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562–1566, 1989

    PubMed  Google Scholar 

  25. Taylor D, Blaser MJ: The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42–59, 1991

    PubMed  Google Scholar 

  26. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332–335, 1991

    PubMed  Google Scholar 

  27. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Perez-Perez GI, Blaser MJ: Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 33:1496–1500, 1995

    PubMed  Google Scholar 

  28. Atherton JC, Cao P, Peek, Jr RM, Tummurn MKR, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 270:17771–17777, 1995

    PubMed  Google Scholar 

  29. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH: Is Barrett's metaplasia the source of adenocarcinoma of the cardia? Arch Surg 129:609–614, 1994

    PubMed  Google Scholar 

  30. Sampliner RE: Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence? Ann Intern Med 130:67–69, 1999

    PubMed  Google Scholar 

  31. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM: Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 87:927–933, 1984

    PubMed  Google Scholar 

  32. Sontag SJ, Schnell TG, Chejfec G, O'Connell S, Stanley MM, Best W, Chintam R, Nemchausky B, Wanner J, Moroni B: Barrett's oesophagus and colonic tumours. Lancet 1:946–949, 1985

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, SS., Lu, CL., Chao, JY. et al. Unchanging Trend of Adenocarcinoma of the Esophagus and Gastric Cardia in Taiwan: A 15-Year Experience in a Single Center. Dig Dis Sci 47, 735–740 (2002). https://doi.org/10.1023/A:1014771429546

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014771429546

Navigation